Evaluation of the effectiveness of Metformin and Curcumin in pcos

Phase 2

Recruiting

• Conditions: Polycystic Ovarian Syndrom.; Endocrine, nutritional and metabolic diseases

• Registration Number: IRCT20221117056528N1
• Lead Sponsor: Zahedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

Women with polycystic ovarian syndrom based on the diagnostic criteria of rotterdam including ultrasound examination and symptoms of hyperandrogenism and menstural disorders and ruling out other endocrine disorderssuch as hyperprolactinemia,increase in the thickness of the outer layer of the ovary,cushing syndrom,acromegaly,androgen producing tumors and CAH

Exclusion Criteria

Cardiovascular disease
Hepatic disease
Renal disease
Thyroid disease
Sever glucose intolerance
User of vitamine and mineral supplementary
User of weight reducer drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ipid profile level. Timepoint: First and three months after the study. Method of measurement: with laboratory sampling in mg/dL.;Hormone profile levels such as testosterone and luteinizing hormone and Follicle-stimulating Hormone. Timepoint: First and three months after the study. Method of measurement: with laboratory sampling in IU/l.;Fasting blood sugar and insulin levels and HOMA-IR. Timepoint: First and three months after the study. Method of measurement: with laboratory sampling in mg/dL.;Average anthropometric indices such as waist circumference and hip circumference and body mass index. Timepoint: First and three months after the study. Method of measurement: By measuring weight in kilograms and height in centimeters.